Meiji Seika Kaisha, Ltd.

Meiji Seika Pharma Co., Ltd.

Meui Seika Kaisha, Ltd.

Goh Tsujiuchi

Takashi Yaguchi

Nobuaki Kushida

Akitaka Nakane

Fumikazu Yokoyama

Tatsuki Moriya

Takayoshi Fukushima

Masato Tani

Naoko Watanabe

Takako Okuda

A novel endoglucanase PPCE derived from, a cellulase preparation containing the endoglucanase PPCE, and a method of treating a cellulose-containing fabric utilizing the endoglucanase PPCE or the cellulase preparation, are disclosed. The endoglucanase PPCE is highly active to a fabric, and has a low optimum temperature and a strongly acidic optimum pH.

Endoglucanase PPCE and cellulase preparation containing the same

This invention provides novel PF1270A substance, PF1270B substance and PF1270C substance represented by the following formula (1) or pharmaceutically acceptable salts thereof, a method for producing the same and a pharmaceutical composition which comprises at least one of the same as the active ingredient. Since a group of the PF1270 substances of the invention show high affinity for histamine Hreceptor, they are expected as novel histamine Hreceptor ligands useful as medicaments. 

Physiologically active substances PF1270A, B and C substances

An objective of the present invention is to provide a method of producing soyasapogenol B and to provide novel microorganisms. The present invention provides a method of producing soyasapogenol B comprising the steps of culturing microorganisms that belong to genusor genus, in a medium containing a glycoside having soyasapogenol B as an aglycone, and then collecting soyasapogenol B from the resulting culture.

Process for producing soyasapogenol B and novel microorganisms

Growing community of inventors

Odawara, Japan

Goh Tsujiuchi